Document_and_Entity_Informatio
Document and Entity Information | 3 Months Ended | |
Mar. 31, 2015 | 14-May-15 | |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | Yew Bio-Pharm Group, Inc. | |
Entity Central Index Key | 1548240 | |
Amendment Flag | FALSE | |
Current Fiscal Year End Date | -19 | |
Document Type | 10-Q | |
Document Period End Date | 31-Mar-15 | |
Document Fiscal Year Focus | 2015 | |
Document Fiscal Period Focus | Q1 | |
Entity Filer Category | Smaller Reporting Company | |
Entity Common Stock, Shares Outstanding | 52,125,000 |
Consolidated_Balance_Sheets
Consolidated Balance Sheets (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
CURRENT ASSETS: | ||
Cash | $129,702 | $487,940 |
Accounts receivable | 2,014,607 | 922,564 |
Accounts receivable - related party | 1,214,172 | 340,132 |
Inventories | 2,700,809 | 1,443,078 |
Prepaid expenses - related party | 5,787 | |
Prepaid expenses and other assets | 39,208 | 16,791 |
Total Current Assets | 6,098,498 | 3,216,292 |
LONG-TERM ASSETS: | ||
Long-term inventories, net | 10,869,884 | 10,663,545 |
Property and equipment, net | 828,654 | 856,250 |
Land use rights and yew forest assets, net | 20,070,176 | 20,305,821 |
Total Long-term Assets | 31,768,714 | 31,825,616 |
Total Assets | 37,867,212 | 35,041,908 |
CURRENT LIABILITIES: | ||
Accounts payable | 1,217,282 | |
Accrued expenses and other payables | 134,779 | 84,722 |
Taxes payable | 47,784 | 10,547 |
Due to related parties | 46,903 | 45,040 |
Total Current Liabilities | 1,446,748 | 140,309 |
Total Liabilities | 1,446,748 | 140,309 |
SHAREHOLDERS' EQUITY: | ||
Common Stock ($0.001 par value; 140,000,000 shares authorized; 52,125,000 shares issued and outstanding at March 31, 2015 and December 31, 2014) | 52,125 | 52,125 |
Additional paid-in capital | 8,860,278 | 8,557,656 |
Retained earnings | 21,269,775 | 20,444,667 |
Statutory reserves | 3,234,048 | 3,100,766 |
Accumulated other comprehensive income - foreign currency translation adjustment | 3,004,238 | 2,746,385 |
Total Shareholders' Equity | 36,420,464 | 34,901,599 |
Total Liabilities and Shareholders' Equity | $37,867,212 | $35,041,908 |
Consolidated_Balance_Sheets_Pa
Consolidated Balance Sheets (Parenthetical) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
Balance Sheets [Abstract] | ||
Common stock, par value | $0.00 | $0.00 |
Common stock, shares authorized | 140,000,000 | 140,000,000 |
Common stock, shares issued | 52,125,000 | 52,125,000 |
Common stock, shares outstanding | 52,125,000 | 52,125,000 |
Consolidated_Statements_of_Inc
Consolidated Statements of Income and Comprehensive Income (Unaudited) (USD $) | 3 Months Ended | |
Mar. 31, 2015 | Mar. 31, 2014 | |
REVENUES: | ||
Revenues | $1,534,654 | $1,613,718 |
Revenues - related party | 1,107,801 | 454,259 |
Total Revenues | 2,642,455 | 2,067,977 |
COST OF REVENUES: | ||
Cost of revenues | 374,045 | 414,616 |
Cost of revenues - related party | 796,924 | 113,118 |
Total Cost of Revenues | 1,170,969 | 527,734 |
GROSS PROFIT | 1,471,486 | 1,540,243 |
OPERATING EXPENSES: | ||
Selling | 4,688 | 1,760 |
General and administrative | 467,378 | 163,494 |
Total Operating Expenses | 472,066 | 165,254 |
INCOME FROM OPERATIONS | 999,420 | 1,374,989 |
OTHER INCOME: | ||
Interest income | 125 | 236 |
Other income (expense) | -16 | 16 |
Total Other Income | 109 | 252 |
NET INCOME BEFORE INCOME TAXES | 999,529 | 1,375,241 |
PROVISION FOR INCOME TAXES | -41,139 | |
NET INCOME | 958,390 | 1,375,241 |
COMPREHENSIVE INCOME: | ||
NET INCOME | 958,390 | 1,375,241 |
OTHER COMPREHENSIVE INCOME (LOSS): | ||
Unrealized foreign currency translation gain (loss) | 257,853 | -257,968 |
COMPREHENSIVE INCOME | $1,216,243 | $1,117,273 |
NET INCOME PER COMMON SHARE: | ||
Basic | $0.02 | $0.03 |
Diluted | $0.02 | $0.02 |
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: | ||
Basic | 52,125,000 | 50,000,000 |
Diluted | 58,225,591 | 68,118,682 |
Consolidated_Statements_of_Cas
Consolidated Statements of Cash Flows (Unaudited) (USD $) | 3 Months Ended | |
Mar. 31, 2015 | Mar. 31, 2014 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net income | $958,390 | $1,375,241 |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||
Depreciation | 37,984 | 46,408 |
Stock-based compensation | 294,239 | |
Stock issued for professional services | 8,383 | |
Amortization of land use rights and yew forest assets | 127,686 | 128,546 |
Gain on disposal of property and equipment | -2,142 | |
Changes in operating assets and liabilities: | ||
Accounts receivable | -1,080,615 | -1,432,302 |
Accounts receivable - related party | -867,776 | 35,949 |
Prepaid expenses and other current assets | -22,281 | -14,005 |
Prepaid expenses- related party | 5,804 | |
Due from related parties | 7,045 | |
Inventories | -1,119,041 | 264,439 |
Accounts payable | 1,214,805 | |
Accrued expenses and other payables | 49,426 | 15,148 |
Taxes payable | 37,016 | -8,320 |
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES | -355,980 | 416,007 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Proceeds from disposal of property and equipment | 5,000 | |
Loan made to related parties | -58,825 | |
Purchase of property and equipment | -4,617 | |
NET CASH USED IN INVESTING ACTIVITIES | -4,617 | -53,825 |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Proceeds from related party advances | 1,834 | |
Repayments for related party advances | -1,420,521 | |
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES | 1,834 | -1,420,521 |
EFFECT OF EXCHANGE RATE ON CASH | 525 | -1,768 |
NET DECREASE IN CASH | -358,238 | -1,060,107 |
CASH - beginning of period | 487,940 | 1,159,611 |
CASH - end of period | 129,702 | 99,504 |
Cash paid for: | ||
Interest | ||
Income taxes | ||
Non-cash investing and financing activities | ||
Reclassification of yew forest assets to inventories | $253,872 | $610,193 |
Organization_and_Principal_Act
Organization and Principal Activities | 3 Months Ended | ||||||||
Mar. 31, 2015 | |||||||||
Organization and Principal Activities [Abstract] | |||||||||
ORGANIZATION AND PRINCIPAL ACTIVITIES | NOTE 1 - ORGANIZATION AND PRINCIPAL ACTIVITIES | ||||||||
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted as permitted by rules and regulations of the Securities and Exchange Commission (“SEC”). The condensed consolidated balance sheet as of December 31, 2014 was derived from the audited consolidated financial statements of Yew Bio-Pharm Group, Inc. (individually “YBP” and collectively with its subsidiaries and operating variable interest entity, the “Company”). The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the summary of significant accounting policies and notes to consolidated financial statements included in the Company’s annual report on Form 10-K for the year ended December 31, 2014. | |||||||||
In the opinion of management, all adjustments (which include normal recurring adjustments) necessary to present a fair statement of the financial position as of March 31, 2015, and the results of operations and cash flows for the three-month periods ended March 31, 2015 and 2014, have been made. | |||||||||
The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company continually evaluates its estimates, including those related to bad debts, inventories, recovery of long-lived assets, income taxes, and the valuation of equity transactions. The Company bases its estimates on historical experience and on various other assumptions that it believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Any future changes to these estimates and assumptions could cause a material change to our reported amounts of revenues, expenses, assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. | |||||||||
Details of the Company’s subsidiaries and variable interest entities (“VIE”) are as follows: | |||||||||
Name | Domicile and Date of Incorporation | Registered | Effective | Principal Activities | |||||
Capital | Ownership | ||||||||
Heilongjiang Jinshangjing Bio-Technology Development Co., Limited (“JSJ”) | PRC | US$100,000 | 100% | Holding company | |||||
29-Oct-09 | |||||||||
Yew Bio-Pharm Holdings Limited (“Yew Bio-Pharm (HK)”) | Hong Kong | HK$10,000 | 100% | Holding company of JSJ | |||||
29-Nov-10 | |||||||||
Harbin Yew Science and Technology Development Co., Ltd. (“HDS”) | PRC | RMB45,000,000 | Contractual arrangements | Sales of yew tree components for use in pharmaceutical industry; sales of yew tree seedlings and potted yew trees; manufacture of yew tree wood handicrafts; and sales of wood ear mushroom | |||||
22-Aug-96 | |||||||||
Harbin Yew Food Co., Ltd ("HYF") | PRC | RMB100,000(1) | 100% | Sales of wood ear mushroom | |||||
4-Nov-14 | |||||||||
(1) Harbin Yew Food Co. Ltd did not pay the registered capital as of March 31, 2015. |
Principles_of_Consolidation
Principles of Consolidation | 3 Months Ended | ||||||||
Mar. 31, 2015 | |||||||||
Principles of Consolidation [Abstract] | |||||||||
PRINCIPLES OF CONSOLIDATION | NOTE 2 – PRINCIPLES OF CONSOLIDATION | ||||||||
The consolidated financial statements include the financial statements of YBP, its subsidiaries and operating VIE, in which the Company is the primary beneficiary. All significant intercompany balances and transactions have been eliminated on consolidation. | |||||||||
Pursuant to a restructuring plan intended to ensure compliance with applicable PRC laws and regulations (the “Second Restructure”), on November 5, 2010, JSJ entered into a series of contractual arrangements (the “Contractual Arrangements”) with HDS and/or Zhiguo Wang, his wife Guifang Qi and Xingming Han (collectively with Mr. Wang and Madame Qi, the “HDS Shareholders”), as described below: | |||||||||
● | Exclusive Business Cooperation Agreement. Pursuant to the Exclusive Business Cooperation Agreement between JSJ and HDS (the “Business Cooperation Agreement”), JSJ has the exclusive right to provide to HDS general business operation services, including advice and strategic planning, as well as consulting services related to technology, research and development, human resources, marketing and other services deemed necessary (collectively, the “Services”). Under the Business Cooperation Agreement, JSJ has exclusive and proprietary rights and interests in all rights, ownership, interests and intellectual properties arising out of or created during the performance of the Business Cooperation Agreement, including but not limited to copyrights, patents, patent applications, software and trade secrets. HDS shall pay to JSJ a monthly consulting service fee (the “Service Fee”) in RMB that is equal to 100% of the monthly net income of HDS. Upon the prior written consent by JSJ, the rate of Service Fee may be adjusted pursuant to the operational needs of HDS. Within 30 days after the end of each month, HDS shall (a) deliver to JSJ the management accounts and operating statistics of HDS for such month, including the net income of HDS during such month (the “Monthly Net Income”), and (b) pay 80% of such Monthly Net Income to JSJ (each such payment, a “Monthly Payment”). Within ninety (90) days after the end of each fiscal year, HDS shall (a) deliver to JSJ financial statements of HDS for such fiscal year, which shall be audited and certified by an independent certified public accountant approved by JSJ, and (b) pay an amount to JSJ equal to the shortfall, if any, of the aggregate net income of HDS for such fiscal year, as shown in such audited financial statements, as compared to the aggregate amount of the Monthly Payments paid by HDS to JSJ in such fiscal year. HDS also granted an irrevocable and exclusive option to JSJ to purchase any and all of the assets of HDS, to the extent permitted under PRC law, at the lowest price permitted by PRC law. Unless earlier terminated in accordance with the provisions of the Business Cooperation Agreement or other agreements separately executed between JSJ and HDS, the Business Cooperation Agreement is for a term of ten years and expires on November 5, 2020; however, the term of the Business Cooperation Agreement may be extended if confirmed in writing by JSJ prior to the expiration of the term thereof. The period of the extended term shall be determined exclusively by JSJ and HDS shall accept such extended term unconditionally. Unless JSJ commits gross negligence, or a fraudulent act, against HDS, HDS shall not terminate the Business Cooperation Agreement prior to the expiration of the term, including any extended term. Notwithstanding the foregoing, JSJ shall have the right to terminate the Business Cooperation Agreement at any time upon giving 30 days’ prior written notice to HDS. | ||||||||
● | Exclusive Option Agreement. Under an Exclusive Option Agreement among JSJ, HDS and each HDS Shareholder (individually, an “Option Agreement”), the terms of which are substantively identical to each other, each HDS Shareholder has granted JSJ or its designee the irrevocable and exclusive right to purchase, to the extent permitted under PRC law, all or any part of the HDS Shareholder’s equity interests in HDS (the “Equity Interest Purchase Option”) for RMB10. If an appraisal is required by PRC laws at the time when and if JSJ exercises the Equity Interest Purchase Option, the parties shall negotiate in good faith and, based upon the appraisal, make a necessary adjustment to the purchase price so that it complies with any and all then applicable PRC laws. Without the consent of JSJ, the HDS Shareholders shall not sell, transfer, mortgage or dispose of their respective shares of HDS stock. Additionally, without the prior consent of JSJ, the HDS Shareholders shall not in any manner supplement, change or amend the articles of association and bylaws of HDS, increase or decrease its registered capital, change the structure of its registered capital in any other manner, or engage in any transactions that could materially affect HDS’ assets, liabilities, rights or operations, including, without limitation, the incurrence or assumption of any indebtedness except incurred in the ordinary course of business, execute any major contract over RMB500,000, sell or purchase any assets or rights, incur of any encumbrance on any of its assets or intellectual property rights in favor of a third party or transfer of any agreements relating to its business operation to any third party. The term of each Option Agreement is ten years commencing on November 5, 2020 and may be extended at the sole election of JSJ. | ||||||||
● | Equity Interest Pledge Agreement. In order to guarantee HDS’s performance of its obligations under the Business Cooperation Agreement, each HDS Shareholder, JSJ and HDS entered into an Equity Interest Pledge Agreement (individually, a “Pledge Agreement”), the terms of which are substantially similar to each other. Pursuant to the Pledge Agreement, each HDS Shareholder pledged all of his or her equity interest in HDS to JSJ. If HDS or the HDS Shareholders breach their respective contractual obligations and such breach is not remedied to the satisfaction of JSJ within 20 days after the giving of notice of breach, JSJ, as pledgee, will be entitled to exercise certain rights, including the right to foreclose upon and sell the pledged equity interests. During the term of the Pledge Agreement, the HDS Shareholder shall not transfer his or her equity interest in HDS or place or otherwise permit any other security interest of other encumbrance to be placed on such equity interest. Upon the full payment of the Service Fee under the Business Cooperation Agreement and upon the termination of HDS’s obligations thereunder, the Pledge Agreement shall be terminated. | ||||||||
● | Power of Attorney. Under the Power of Attorney executed by each HDS Shareholder (each, a “Power of Attorney”), the terms of which are substantially similar to each other, JSJ has been granted an exclusive, irrevocable power of attorney to take actions in the place and stead of the HDS Shareholders, to act on behalf of the HDS Shareholder as his or her exclusive agent and attorney with respect to all matters concerning the HDS Shareholder’s equity interests in HDS, including without limitation, the right to: 1) attend shareholders’ meetings of HDS; 2) exercise all the HDS Shareholders’ rights, including voting rights under PRC laws and HDS’s Articles of Association, including but not limited to the sale or transfer or pledge or disposition of the HDS Shareholder’s equity interests in HDS in whole or in part; and 3) designate and appoint on behalf of the HDS Shareholders the legal representative, executive director, supervisor, manager and other senior management of HDS. | ||||||||
To the extent that the Contractual Arrangements are enforceable under PRC law, as from time to time interpreted by relevant state agencies, they constitute the valid and binding obligations of each of the parties to each such agreement. | |||||||||
The Company believes that HDS is considered a VIE under ASC 810 “Consolidation”, because the equity investors in HDS no longer have the characteristics of a controlling financial interest, and the Company, through JSJ, is the primary beneficiary of HDS and controls HDS’s operations. Accordingly, HDS has been consolidated as a deemed subsidiary into YBP as a reporting company under ASC 810. | |||||||||
As required by ASC 810-10, the Company performs a qualitative assessment to determine whether the Company is the primary beneficiary of HDS which is identified as a VIE of the Company. A quality assessment begins with an understanding of the nature of the risks in the entity as well as the nature of the entity’s activities including terms of the contracts entered into by the entity, ownership interests issued by the entity and the parties involved in the design of the entity. The Company’s assessment on the involvement with HDS reveals that the Company has the absolute power to direct the most significant activities that impact the economic performance of HDS. JSJ is obligated to absorb a majority of the risk of loss from HDS activities and entitles JSJ to receive a majority of HDS’s expected residual returns. In addition, HDS’s shareholders have pledged their equity interest in HDS to JSJ, irrevocably granted JSJ an exclusive option to purchase, to the extent permitted under PRC Law, all or part of the equity interests in HDS and agreed to entrust all the rights to exercise their voting power to the person(s) appointed by JSJ. Under the accounting guidance, the Company is deemed to be the primary beneficiary of HDS and the results of HDS are consolidated in the Company’s consolidated financial statements for financial reporting purposes. Accordingly, as a VIE, HDS’s sales are included in the Company’s total sales, its income from operations is consolidated with the Company’s and the Company’s net income includes all of HDS’s net income. The Company does not have any non-controlling interest and, accordingly, did not subtract any net income in calculating the net income attributable to the Company. Because of the Contractual Arrangements, YBP has a pecuniary interest in HDS that requires consolidation of HDS’s financial statements with those of the Company. | |||||||||
Additionally, pursuant to ASC 805, as YBP and HDS are under the common control of the HDS Shareholders, the Second Restructure was accounted for in a manner similar to a pooling of interests. As a result, the Company’s historical amounts in the accompanying consolidated financial statements give retrospective effect to the Second Restructure, whereby the assets and liabilities of the Company are reflected at the historical carrying values and their operations are presented as if they were consolidated for all periods presented, with the results of the Company being consolidated from the date of the Second Transfer Agreement. The accounts of HDS are consolidated in the accompanying financial statements. | |||||||||
As of March 31, 2015, the Company agreed to waive all management fees to be payable by HDS and the Company expects to waive such management fees in the near future due to a need of working capital in HDS to expand HDS’ operations. | |||||||||
The Company is principally engaged in (1) processing and selling yew raw materials used in the manufacture of traditional Chinese medicine (“TCM”); (2) growing and selling yew tree seedlings and mature trees, including potted miniature yew trees; (3) manufacturing and selling furniture and handicrafts made of yew tree timber; and (4) selling wood ear mushroom as finished goods. The Company is located in Harbin, Heilongjiang Province, China. | |||||||||
YBP has no direct or indirect legal or equity ownership interest in HDS. However, through the Contractual Arrangements, the stockholders of HDS have assigned all their rights as stockholders, including voting rights and disposition rights of their equity interests in HDS to JSJ, our indirect, wholly-owned subsidiary. YBP is deemed to be the primary beneficiary of HDS and the financial statements of HDS are consolidated in the Company’s consolidated financial statements. At March 31, 2015 and December 31, 2014, the carrying amount and classification of the assets and liabilities in the Company’s balance sheets that relate to the Company’s variable interest in the VIE are as follows: | |||||||||
March 31, | December 31, | ||||||||
2015 | 2014 | ||||||||
Assets | |||||||||
Cash | $ | 107,402 | $ | 446,554 | |||||
Accounts receivable | 2,014,607 | 922,564 | |||||||
Accounts receivable – related party | 1,214,172 | 340,132 | |||||||
Inventories (current and long-term), net | 12,922,693 | 12,106,623 | |||||||
Prepaid expenses and other assets | 27,942 | 5,363 | |||||||
Prepaid expenses - related party | - | 6,600 | |||||||
Property and equipment, net | 786,544 | 814,676 | |||||||
Land use rights and yew forest assets, net | 20,070,176 | 20,305,822 | |||||||
Total assets of VIE | $ | 37,143,536 | $ | 34,948,334 | |||||
Liabilities | |||||||||
Accounts payable | $ | 569,282 | $ | - | |||||
Accrued expenses and other payables | 677,623 | 54,265 | |||||||
Taxes payable | 45,478 | 8,104 | |||||||
Due to VIE holding companies | 1,359,297 | 1,417,851 | |||||||
Due to related parties | 3,593 | 2,958 | |||||||
Total liabilities of VIE | $ | 2,085,992 | $ | 1,483,178 | |||||
The assets and liabilities in the table above are held in HDS, the VIE. The creditors of HDS have legal recourse only to the assets of HDS and do not have such recourse to the Company. In addition, HDS’ assets are generally restricted only to pay such liabilities. Thus, the Company’s maximum legal exposure to loss related to the VIE is significantly less than the carrying value of the HDS’ assets due to outstanding intercompany liabilities. Restricted net assets of the VIE shall mean that amount of our proportionate share of net assets of HDS (after intercompany eliminations) which as of the end of the most recent fiscal year and most recent reporting balance sheet date may not be transferred to the parent company by the VIE in the form of loans, advances or cash dividends without the consent of a third party (e.g. lender, regulatory agency, foreign government). |
Inventories
Inventories | 3 Months Ended | ||||||||||||||||||||||||
Mar. 31, 2015 | |||||||||||||||||||||||||
Inventories [Abstract] | |||||||||||||||||||||||||
INVENTORIES | NOTE 3 – INVENTORIES | ||||||||||||||||||||||||
Inventories consisted of raw materials, work-in-progress, finished goods, yew seedlings and other trees, which consist of larix, spruce and poplar trees. The Company classifies its inventories based on its historical and anticipated levels of sales; any inventory in excess of its normal operating cycle of one year is classified as long-term on its consolidated balance sheets. As of March 31, 2015 and December 31, 2014, inventories consisted of the following: | |||||||||||||||||||||||||
31-Mar-15 | 31-Dec-14 | ||||||||||||||||||||||||
Current | Long-term | Total | Current | Long-term | Total | ||||||||||||||||||||
portion | portion | portion | portion | ||||||||||||||||||||||
Raw materials | $ | 86,390 | $ | 2,818,828 | $ | 2,905,218 | $ | 120,478 | $ | 2,798,489 | $ | 2,918,967 | |||||||||||||
Work-in-process | - | - | - | - | 256,227 | 256,227 | |||||||||||||||||||
Finished goods | 782,934 | 753,319 | 1,536,253 | - | 805,438 | 805,438 | |||||||||||||||||||
Yew seedlings and other trees | 1,831,485 | 7,382,961 | 9,214,446 | 1,322,600 | 6,889,573 | 8,212,173 | |||||||||||||||||||
Total | 2,700,809 | 10,955,108 | 13,655,917 | 1,443,078 | 10,749,727 | 12,192,805 | |||||||||||||||||||
Reserve for impairment - handicrafts | - | (85,224 | ) | (85,224 | ) | - | (86,182 | ) | (86,182 | ) | |||||||||||||||
Inventories, net | $ | 2,700,809 | $ | 10,869,884 | $ | 13,570,693 | $ | 1,443,078 | $ | 10,663,545 | $ | 12,106,623 |
Taxes
Taxes | 3 Months Ended | ||||||||
Mar. 31, 2015 | |||||||||
Taxes [Abstract] | |||||||||
TAXES | NOTE 4 – TAXES | ||||||||
(a) Federal Income Tax and Enterprise Income Taxes | |||||||||
The Company is registered in the State of Nevada and is subject to the United States federal income tax at a tax rate of 34%. No provision for income taxes in the U.S. has been made as the Company had no U.S. taxable income as of March 31, 2015 and December 31, 2014. | |||||||||
The Company’s subsidiaries and VIE, JSJ, HYF and HDS, respectively, incorporated in the PRC, are subject to PRC’s Enterprise Income Tax. Pursuant to the PRC Income Tax Laws, Enterprise Income Taxes (“EIT”) is generally imposed at 25%. However, HDS has been named as a leading enterprise in the agricultural industry and awarded with a tax exemption through December 31, 2058 with an exception of handicrafts and wood ear mushroom sold. JSJ is a holding company and subject to regular corporate income tax rate of 25%, and has no operation profit for tax liabilities. HYF did not have any operation for the three months ended March 31, 2015. | |||||||||
Income before income tax expenses of $999,529 and $1,375,241 for the three months ended March 31, 2015 and 2014, respectively, was attributed to subsidiaries and VIE with operations in China. JSJ and HYF recorded no income tax expense for the three months ended March 31, 2015 and 2014 due to the fact that JSJ has been incurring net losses and HYF did not have any operation since its establishment. HDS recorded income tax expense of $41,139 and zero for the three months ended March 31, 2015 and 2014, respectively. | |||||||||
The combined effects of the income tax expense exemptions and tax reductions available to the Company for the three months ended March 31, 2015 and 2014 are as follows: | |||||||||
Three Months Ended | |||||||||
March 31, | |||||||||
2015 | 2014 | ||||||||
Tax exemption effect | $ | 292,331 | $ | 350,294 | |||||
Tax reduction due to loss carry-forwards | 2,355 | 3,021 | |||||||
Loss not subject to income tax | (378 | ) | (832 | ) | |||||
Basic net income per share effect | $ | (0.01 | ) | $ | (0.01 | ) | |||
Diluted net income per share effect | $ | (0.01 | ) | $ | (0.01 | ) | |||
The table below summarizes the difference between the U.S. statutory federal tax rate and the Company’s effective tax rate for the three months ended March 31, 2015 and 2014: | |||||||||
Three Months Ended | |||||||||
March 31, | |||||||||
2015 | 2014 | ||||||||
U.S. federal income tax rate | 34 | % | 34 | % | |||||
Foreign income not recognized in the U.S. | (34 | )% | (34 | )% | |||||
PRC EIT rate | 25 | % | 25 | % | |||||
PRC tax exemption and reduction | (22 | )% | (25 | )% | |||||
Others | 1 | % | - | ||||||
Total effective income tax rate | 4 | % | - | ||||||
The deferred income tax assets or liabilities calculated pursuant to the EIT are not material due to the fact that the Company has been granted EIT exemption with respect to its yew raw materials and yew tree segments. | |||||||||
The Company incurred net operating losses for U.S. income tax purposes for the three months ended March 31, 2015 and 2014. The net operating loss carry-forwards for U.S. income tax purposes amounted to $3,641,823 and $3,293,117 at March 31, 2015 and 2014, respectively, which may be available to reduce future years’ taxable income. These carry forwards will expire, if not utilized, through 2035. Management believes that the realization of the benefits arising from this loss appear to be uncertain due to the Company’s limited operating history and continuing losses for United States income tax purposes. Accordingly, the Company has provided a 100% valuation allowance on the deferred tax asset to reduce the asset to zero at March 31, 2015 and 2014. The valuation allowance at March 31, 2015 and 2014 was $1,238,220 and $1,119,660, respectively. The net change in the valuation allowance was a decrease of $121,864 and an increase of $11,795 during the three months ended March 31, 2015 and 2014, respectively. Management reviews this valuation allowance periodically and makes adjustments as necessary. | |||||||||
Deferred tax assets and liabilities are provided for significant income and expense items recognized in different years for income tax and financial reporting purposes. Temporary differences, which give rise to a net deferred tax asset for the Company as of March 31, 2015 and 2014, are as follows: | |||||||||
March 31, | March 31, | ||||||||
2015 | 2014 | ||||||||
U.S. tax benefit of net operating loss carry forward | $ | 1,238,220 | $ | 1,119,660 | |||||
Valuation allowance | (1,238,220 | ) | (1,119,660 | ) | |||||
Net deferred tax assets | $ | - | $ | - | |||||
For U.S. income tax purposes, the Company has cumulative undistributed earnings of foreign subsidiary and VIE of approximately $25.9 million and $24.7 million as of March 31, 2015 and December 31, 2014, respectively, which are included in consolidated retained earnings and will continue to be indefinitely reinvested in overseas operations. Accordingly, no provision has been made for U.S. deferred taxes related to future repatriation of these earnings, nor is it practicable to estimate the amount of income taxes that would have to be provided if we concluded that such earnings will be remitted to the U.S. in the future. | |||||||||
(b) Value Added Taxes (“VAT”) | |||||||||
The applicable VAT tax rate is 13% for agricultural products and 17% for handicrafts sold in the PRC. In accordance with VAT regulations in the PRC, the Company is exempt from paying VAT on its yew raw materials and yew trees sales as an agricultural corps cultivating company up to December 31, 2016. VAT payable in the PRC is charged on an aggregated basis at the applicable rate on the full price collected for the goods sold or taxable services provided and less any deductible VAT already paid by the taxpayer on purchases of goods in the same fiscal year. |
Stockholders_Equity
Stockholders' Equity | 3 Months Ended | ||||||||||||||||||||||
Mar. 31, 2015 | |||||||||||||||||||||||
Stockholders' Equity [Abstract] | |||||||||||||||||||||||
STOCKHOLDERS' EQUITY | NOTE 5 – STOCKHOLDERS’ EQUITY | ||||||||||||||||||||||
(a) Common Stock | |||||||||||||||||||||||
On July 22, 2014, the Company entered into a Service Provider Agreement (the “SPA”) with a service provider to commence service on July 22, 2014 for a period of three years. Pursuant to the SPA, the Company agreed to issue to the service provider 1,250,000 shares of its Rule 144 restricted common stock for the service period. The shares are payable in 875,000 shares of its restricted common stock on or before July 22, 2014 for the first year of service under the SPA and 375,000 shares of its restricted common stock to be issued on or before July 22, 2015, for the second and third year of service under the SPA. For the three months ended March 31, 2015, a total of $8,383 was expensed under the SPA. | |||||||||||||||||||||||
(b) Stock Options | |||||||||||||||||||||||
On July 18, 2014, the Company’s board of directors in lieu of an established compensation committee granted options pursuant to the Corporation’s 2012 Equity Incentive Plan to two directors and one of its employees (the “Optionees I”). Within the stock option agreement, each of the Optionees I was issued 200,000 shares of common stock of the Company at an exercise price of $0.20 per share. The option has a term of four years and expires on August 1, 2018 from August 1, 2014, vesting commencement date. The options vest over a three-year time period from August 1, 2014, and 30%, 35%, and 35% of the total shares granted shall vest and become exercisable 12, 24, and 36 months after the initial vesting commencement date. | |||||||||||||||||||||||
On November 18, 2014, the Company’s board of directors in lieu of an established compensation committee granted options pursuant to the Corporation’s 2012 Equity Incentive Plan to the Company’s employees (the “Optionees II”). Within the stock option agreement, each of the Optionees II was issued shares of common stock of the Company at an exercise price of $0.23 per share. There are three types of term for the subject stock options granted. (1) The option has a term of four years starting from November 18, 2014, the vesting commencement date, and expires on November 18, 2018. The options vest over a three-year time period from November 18, 2014, and 30%, 35%, and 35% of the total shares granted shall vest and become exercisable 12, 24, and 36 months after the initial vesting commencement date. (2) The option has a term of two years starting from November 18, 2014, the vesting commencement date, and expires on November 18, 2016. The options vest over a one-year time period from November 18, 2014, and 100% of the total shares granted shall vest and become exercisable 12 months after the initial vesting commencement date. (3) The option has a term of three years starting from November 18, 2014, the vesting commencement date, and expires on November 18, 2017. The options vest over a two-year time period, and 50% and the remaining 50% of the total shares shall vest and become exercisable 12 and 24 months respectively after the initial vesting commencement date. | |||||||||||||||||||||||
There were no stock options issued, terminated/forfeited and exercised during the three months ended March 31, 2015. | |||||||||||||||||||||||
The following table summarizes the shares of the Company's common stock issuable upon exercise of options outstanding at March 31, 2015: | |||||||||||||||||||||||
Stock Options Outstanding | Stock Options Exercisable | ||||||||||||||||||||||
Range of | Number | Weighted Average | Weighted | Number | Weighted | ||||||||||||||||||
Exercise Price | Outstanding at | Remaining | Average | Exercisable at | Average | ||||||||||||||||||
March 31, | Contractual Life | Exercise Price | March 31, | Exercise Price | |||||||||||||||||||
2015 | (Years) | 2015 | |||||||||||||||||||||
$ | 0.20-0.23 | 27,205,512 | 2.77 | $ | 0.26 | 22,805,512 | $ | 0.22 | |||||||||||||||
The aggregate intrinsic value amounted to $1,878,386 and $1,596,386 for outstanding stock options and exercisable stock options, respectively, which is based upon the Company’s closing stock price of $0.29 as of March 31, 2015, which would have been received by the option holders had all option holders exercised their option awards as of that date. Stock option expense recognized during the three months ended March 31, 2015 amounted to $294,239. | |||||||||||||||||||||||
Earnings_per_Share
Earnings per Share | 3 Months Ended | ||||||||
Mar. 31, 2015 | |||||||||
Earnings Per Share [Abstract] | |||||||||
EARNINGS PER SHARE | NOTE 6 – EARNINGS PER SHARE | ||||||||
The following table presents a reconciliation of basic and diluted net income per share for the three months ended March 31, 2015 and 2014: | |||||||||
For the Three Months | |||||||||
Ended March 31, | |||||||||
2015 | 2014 | ||||||||
Net income available to common stockholders for basic and diluted net income per share of common stock | $ | 958,390 | $ | 1,375,241 | |||||
Weighted average common stock outstanding – basic | 52,125,000 | 50,000,000 | |||||||
Effect of dilutive securities: | |||||||||
Non-vested restricted common stock | 58,877 | - | |||||||
Stock options issued to directors/officers/employees | 6,041,714 | 18,118,682 | |||||||
Weighted average common stock outstanding – diluted | 58,225,591 | 68,118,682 | |||||||
Net income per common share – basic | $ | 0.02 | $ | 0.03 | |||||
Net income per common share – diluted | $ | 0.02 | $ | 0.02 |
Concentrations_of_Credit_Risk_
Concentrations of Credit Risk and Major Customers | 3 Months Ended | ||||||||
Mar. 31, 2015 | |||||||||
Concentrations of Credit Risk and Major Customers [Abstract] | |||||||||
CONCENTRATIONS OF CREDIT RISK AND MAJOR CUSTOMERS | NOTE 7 – CONCENTRATIONS OF CREDIT RISK AND MAJOR CUSTOMERS | ||||||||
Customers | |||||||||
For the three months ended March 31, 2015 and 2014, customers accounting for 10% or more of the Company’s revenue are as follows: | |||||||||
For the Three Months | |||||||||
Ended March 31, | |||||||||
Customer | 2015 | 2014 | |||||||
A (Yew Pharmaceutical, a related party) | 41.92 | % | 21.97 | % | |||||
B | * | % | * | % | |||||
C | * | % | * | % | |||||
* Less than 10% | |||||||||
The three largest customers accounted for 49% and 36% of the Company’s total outstanding accounts receivable at March 31, 2015 and December 31, 2014, respectively, of which Heilongjiang Yew Pharmaceutical Co., Ltd., (“Yew Pharmaceutical”), a related party, accounted for 38% and 27% of total outstanding accounts receivable, respectively. | |||||||||
Suppliers | |||||||||
For the three months ended March 31, 2015 and 2014, suppliers accounting for 10% or more of the Company’s purchase are as follows: | |||||||||
For the Three Months | |||||||||
Ended March 31, | |||||||||
Supplier | 2015 | 2014 | |||||||
A | 25 | % | * | % | |||||
B | 20 | % | * | % | |||||
C | 10 | % | * | % | |||||
The three largest suppliers accounted for 55% of the Company’s total purchase for the three months ended March 31, 2015 and these suppliers accounted for 15% of total accounts payable at March 31, 2015. The ending balance of accounts payable was zero at December 31, 2014. | |||||||||
For the three months ended March 31, 2014, the Company did not make any significant purchases. |
Related_Party_Transactions
Related Party Transactions | 3 Months Ended | ||
Mar. 31, 2015 | |||
Related Party Transactions [Abstract] | |||
RELATED PARTY TRANSACTIONS | NOTE 8 – RELATED PARTY TRANSACTIONS | ||
In addition to several of the Company’s officers and directors, the Company conducted transactions with the following related parties: | |||
Company | Ownership | ||
Heilongjiang Zishan Technology Stock Co., Ltd. (“ZTC”) | 18% owned by Heilongjiang Hongdoushan Ecology Forest Stock Co., Ltd., 39% owned by Zhiguo Wang, Chairman and Chief Executive Officer, 31% owned by Guifang Qi, the wife of Mr. Wang and director of the Company, and 12% owned by third parties. | ||
Heilongjiang Yew Pharmaceutical Co., Ltd. (“Yew Pharmaceutical”) | 95% owned by Heilongjiang Hongdoushan Ecology Forest Stock Co., Ltd., and 5% owned by Madame Qi. | ||
Shanghai Kairun Bio-Pharmaceutical Co., Ltd. (“Kairun”) | 60% owned by Heilongjiang Zishan Technology Co., Ltd., 20% owned by Heilongjiang Hongdoushan Ecology Forest Stock Co., Ltd., and 20% owned by Mr. Wang. | ||
Heilongjiang Hongdoushan Ecology Forest Stock Co., Ltd. (“HEFS”) | 63% owned by Mr. Wang, 34% owned by Madame Qi, and 3% owned by third parties. | ||
Cooperation and Development Agreement and Revenues from Related Party | |||
On January 9, 2010, the Company entered into a Cooperation and Development Agreement (the “Development Agreement”) with Yew Pharmaceutical. Pursuant to the Development Agreement, for a period of ten years expiring on January 9, 2020, the Company shall supply cultivated yew raw materials to Yew Pharmaceutical that will be used by Yew Pharmaceutical to make traditional Chinese medicines and other pharmaceutical products, at price of RMB1,000,000 (approximately $158,000) per metric ton. In addition, the Company entered into a series of wood ear mushroom selling agreements with Pharmaceuticals, pursuant to which the Company sells wood ear mushroom collected from local peasants to Yew Pharmaceuticals for manufacturing of wood ear mushroom products. | |||
For the three months ended March 31, 2015 and 2014, total sales to Yew Pharmaceutical under the above agreement amounted to $1,107,801 and $454,259, respectively. | |||
At March 31, 2015 and December 31, 2014, the Company had $1,214,172 and $340,132 accounts receivable from Yew Pharmaceutical, respectively. | |||
Operating Leases | |||
On March 25, 2005, the Company entered into an Agreement for the Lease of Seedling Land with ZTC (the “ZTC Lease”). Pursuant to the ZTC Lease, the Company leased 361 mu of land from ZTC for a period of 30 years, expiring on March 24, 2035. Annual payments under the ZTC Lease are RMB162,450 (approximately $26,000). The payment for the first five years of the ZTC Lease was due prior to December 31, 2010 and beginning in 2011, the Company was required to make full payment for the land use rights in advance for each subsequent five-year period. For the three months ended March 31, 2015 and 2014, rent expense related to the ZTC Lease amounted to $6,619 and $6,636, respectively. At March 31, 2015 and December 31, 2014, prepaid rent to ZTC amounted to $nil and $6,600 which was included in prepaid expenses – related parties on the accompanying consolidated balance sheets. | |||
On January 1, 2010, the Company entered into a lease for office space with Mr. Wang (the “Office Lease”). Pursuant to the Office Lease, annual payments of RMB15,000 (approximately $2,000) are due for each of the term. The term of the Office Lease is 15 years and expires on December 31, 2025. For the three months ended March 31, 2015 and 2014, rent expense related to the Office Lease amounted to $611 and $613, respectively. | |||
On July 1, 2012, the Company entered into a lease for office space with Mr. Wang (the “JSJ Lease”). Pursuant to the JSJ Lease, JSJ leases approximately 30 square meter of office space from Mr. Wang in Harbin. Rent under the JSJ Lease is RMB10,000 (approximately $1,600) annually. The term of the JSJ Lease is three years and expires on June 30, 2015. For the three months ended March 31, 2015 and 2014, rent expense related to the JSJ Lease amounted to $407 and $409, respectively. | |||
On February 1, 2015, the Company entered into a lease for office and warehouse space with The Realty Associates Fund VIII, L.P. (the “Warehouse Lease”) in Delaware. Pursuant to the Warehouse Lease, YBP leases 3,706 square feet of office and warehouse for a period of thirty six months. Monthly rent payments including operating expenses under the Warehouse Lease are approximately $3,400. The lease expires on January 31, 2018. For the three months ended March 31, 2015, rent expense related to the Warehouse Lease amounted to $6,523. | |||
At March 31, 2015 and December 31, 2014, the total prepaid rent for the above operating leases with related parties amounted to $nil and $5,787, respectively, which amount was included in prepaid expenses-related party on the accompanying consolidated balance sheets. | |||
Due to Related Parties | |||
The Company’s officers, directors and related parties, from time to time, provided advances to the Company for working capital purpose. These advances are short-term in nature, non-interest bearing, unsecured and payable on demand. Due to Zhiguo Wang and other shareholders amounted to $46,903 and $45,040 at March 31, 2015 and December 31, 2014, respectively. | |||
Research and Development Agreement | |||
The Company entered into a Technology Development Service Agreement dated January 1, 2010 (the “Technology Agreement”) with Kairun. The term of the Technology Agreement was two years. Under the Technology Agreement, Kairun provides the Company with testing and technologies regarding utilization of yew trees to extract taxol and develop higher concentration of taxol in the yew trees the Company grow and cultivate. For these services, the Company agreed to pay Kairun RMB200,000 (approximately $32,000) after the technologies developed by Kairun are tested and approved by the Company. The Company will retain all intellectual property rights in connection with the technologies developed by Kairun. Kairun may not provide similar services to any other party without the Company’s prior written consent. In February 2012, we entered into a supplemental agreement with Kairun, extending the term of the Technology Agreement indefinitely until project results specified in the original Technology Agreement have been achieved. Kairun is owned directly and indirectly primarily by Mr. Wang and Madame Qi. As of March 31, 2015, Kairun has not yet completed the services provided for in the Technology Agreement and, therefore, no payment was made to Kairun. |
Statutory_Reserves
Statutory Reserves | 3 Months Ended |
Mar. 31, 2015 | |
Statutory Reserves [Abstract] | |
STATUTORY RESERVES | NOTE 9 – STATUTORY RESERVES |
The Company is required to make appropriations to reserve funds, comprising the statutory surplus reserve and discretionary surplus reserve, based on after-tax net income determined in accordance with generally accepted accounting principles of the PRC (“PRC GAAP”). Appropriation to the statutory surplus reserve is required to be at least 10% of the after tax net income determined in accordance with PRC GAAP until the reserve is equal to 50% of the entities’ registered capital. Appropriations to the discretionary surplus reserve are made at the discretion of the board of directors. | |
The statutory surplus reserve fund is non-distributable other than during liquidation and can be used to fund previous years’ losses, if any, and may be utilized for business expansion or converted into share capital by issuing new shares to existing shareholders in proportion to their shareholding or by increasing the par value of the shares currently held by them, provided that the remaining reserve balance after such issue is not less than 25% of the registered capital. For the three months ended March 31, 2015 and 2014, the Company appropriated to the statutory surplus reserve in the amount of $134,330 and $141,326, respectively. The accumulated balance of the statutory reserve of the Company as of March 31, 2015 and December 31, 2014 was $3,234,048 and $3,100,766, respectively. | |
Segment_Information
Segment Information | 3 Months Ended | ||||||||||||||||||||||||
Mar. 31, 2015 | |||||||||||||||||||||||||
Segment Information [Abstract] | |||||||||||||||||||||||||
SEGMENT INFORMATION | NOTE 10 – SEGMENT INFORMATION | ||||||||||||||||||||||||
ASC 280 requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. Reportable segments are based on products and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company. | |||||||||||||||||||||||||
For the three months ended March 31, 2015, the Company operated in four reportable business segments: (1) the TCM raw materials segment, consisting of the production and sale of yew raw materials used in the manufacture of TCM; (2) the yew tree segment, consisting of the growth and sale of yew tree seedlings and mature trees, including potted miniature yew trees; (3) the handicrafts segment, consisting of the manufacture and sale of handicrafts and furniture made of yew timber; and (4) the wood ear mushroom segment, consisting of the sale of wood ear mushroom. The Company’s reportable segments are strategic business units that offer different products. They are managed separately based on the fundamental differences in their operations. All of the Company’s operations are conducted in the PRC. | |||||||||||||||||||||||||
The Company operated in the TCM segment, yew tree segment, and handicrafts segment for the three months ended March 31, 2014, as the wood ear mushroom segment was not established until the fourth quarter of 2014. | |||||||||||||||||||||||||
Information with respect to these reportable business segments for the three months ended March 31, 2015 and 2014 is as follows: | |||||||||||||||||||||||||
For the Three Months | |||||||||||||||||||||||||
Ended March 31, | |||||||||||||||||||||||||
2015 | 2014 | ||||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||||
TCM raw materials | $ | 957,006 | $ | 1,043,980 | |||||||||||||||||||||
Yew trees | 698,752 | 964,306 | |||||||||||||||||||||||
Handicrafts | 87,508 | 59,691 | |||||||||||||||||||||||
Wood ear mushroom | 899,189 | - | |||||||||||||||||||||||
$ | 2,642,455 | $ | 2,067,977 | ||||||||||||||||||||||
Cost of revenues: | |||||||||||||||||||||||||
TCM raw materials | $ | 148,325 | $ | 232,340 | |||||||||||||||||||||
Yew trees | 244,848 | 249,331 | |||||||||||||||||||||||
Handicrafts | 13,893 | 46,063 | |||||||||||||||||||||||
Wood ear mushroom | 763,903 | - | |||||||||||||||||||||||
$ | 1,170,969 | $ | 527,734 | ||||||||||||||||||||||
Depreciation and amortization: | |||||||||||||||||||||||||
TCM raw materials | $ | 136,831 | $ | 125,736 | |||||||||||||||||||||
Yew trees | 1,616 | 13,700 | |||||||||||||||||||||||
Handicrafts | 7,065 | 7,819 | |||||||||||||||||||||||
Wood ear mushroom | - | - | |||||||||||||||||||||||
Other | 20,158 | 27,699 | |||||||||||||||||||||||
$ | 165,670 | $ | 174,954 | ||||||||||||||||||||||
Net income (loss): | |||||||||||||||||||||||||
TCM raw materials | $ | 808,682 | $ | 796,227 | |||||||||||||||||||||
Yew trees | 453,904 | 694,336 | |||||||||||||||||||||||
Handicrafts | 73,615 | 14,682 | |||||||||||||||||||||||
Wood ear mushroom | 135,286 | - | |||||||||||||||||||||||
Other | (513,097 | ) | (130,004 | ) | |||||||||||||||||||||
$ | 958,390 | $ | 1,375,241 | ||||||||||||||||||||||
31-Mar-15 | |||||||||||||||||||||||||
TCM raw materials | Yew | Handicrafts | Wood ear mushroom | Other | Total | ||||||||||||||||||||
trees | |||||||||||||||||||||||||
Identifiable long-lived assets, net | $ | 19,740,199 | $ | 908,146 | $ | 56,684 | $ | - | $ | 195,469 | $ | 20,900,498 | |||||||||||||
31-Dec-14 | |||||||||||||||||||||||||
TCM raw materials | Yew | Handicrafts | Wood ear | Other | Total | ||||||||||||||||||||
trees | mushroom | ||||||||||||||||||||||||
Identifiable long-lived assets, net | $ | 19,973,775 | $ | 915,551 | $ | 63,319 | $ | - | $ | 209,246 | $ | 21,162,071 | |||||||||||||
The Company does not allocate any selling, general and administrative expenses, other income/expenses to its reportable segments because these activities are managed at a corporate level. In addition, the specified amounts for interest expense and income tax expense are not included in the measure of segment profit or loss reviewed by the chief operating decision maker and these specified amounts are not regularly provided to the chief operating decision maker. Therefore, the Company has not disclosed interest expense and income tax expense for each reportable segment. | |||||||||||||||||||||||||
Asset information by reportable segment is not reported to or reviewed by the chief operating decision maker and, therefore, the Company has not disclosed asset information for each reportable segment. The Company’s operations are located in the PRC. All revenues are derived from customers in the PRC. All of the Company’s operating assets are located in the PRC. |
Recent_Accounting_Pronouncemen
Recent Accounting Pronouncements | 3 Months Ended |
Mar. 31, 2015 | |
Recent Accounting Pronouncements [Abstract] | |
RECENT ACCOUNTING PRONOUNCEMENTS | NOTE 11 – RECENT ACCOUNTING PRONOUNCEMENTS |
In February 2015, the FASB issued ASU 2015-02, “Consolidation (Topic 810): Amendments to the Consolidation Analysis”. The amendments in this Update affect reporting entities that are required to evaluate whether they should consolidate certain legal entities. All legal entities are subject to reevaluation under the revised consolidation model. Specifically, the amendments: 1. Modify the evaluation of whether limited partnerships and similar legal entities are variable interest entities (VIEs) or voting interest entities. 2. Eliminate the presumption that a general partner should consolidate a limited partnership. 3. Affect the consolidation analysis of reporting entities that are involved with VIEs, particularly those that have fee arrangements and related party relationships. 4. Provide a scope exception from consolidation guidance for reporting entities with interests in legal entities that are required to comply with or operate in accordance with requirements that are similar to those in Rule 2a-7 of the Investment Company Act of 1940 for registered money market funds. The ASU will be effective for interim and annual reporting periods beginning after December 15, 2015. Early adoption is permitted. The Company is currently in the process of evaluating the impact of the adoption on its consolidated financial statements. | |
Subsequent_Events
Subsequent Events | 3 Months Ended |
Mar. 31, 2015 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 12 – SUBSEQUENT EVENTS |
On April 23, 2015, HDS entered into a loan agreement with Bank of Communications ("BOCOM") Harbin Rongtong Branch, pursuant to which BOCOM agreed to provide HDS a one-year loan of RMB10,000,000 (approximately $1,630,000) for purchasing raw materials purposes. The loan carries an annual interest rate of 6.955% and is secured by the assets of ZTC which is owned by Mr. Zhiguo Wang, the CEO and principal stock holder of the Company. |
Organization_and_Principal_Act1
Organization and Principal Activities (Tables) | 3 Months Ended | ||||||||
Mar. 31, 2015 | |||||||||
Organization and Principal Activities [Abstract] | |||||||||
Schedule of Company's subsidiaries and variable interest entities | Name | Domicile and Date of Incorporation | Registered | Effective | Principal Activities | ||||
Capital | Ownership | ||||||||
Heilongjiang Jinshangjing Bio-Technology Development Co., Limited (“JSJ”) | PRC | US$100,000 | 100% | Holding company | |||||
29-Oct-09 | |||||||||
Yew Bio-Pharm Holdings Limited (“Yew Bio-Pharm (HK)”) | Hong Kong | HK$10,000 | 100% | Holding company of JSJ | |||||
29-Nov-10 | |||||||||
Harbin Yew Science and Technology Development Co., Ltd. (“HDS”) | PRC | RMB45,000,000 | Contractual arrangements | Sales of yew tree components for use in pharmaceutical industry; sales of yew tree seedlings and potted yew trees; manufacture of yew tree wood handicrafts; and sales of wood ear mushroom | |||||
22-Aug-96 | |||||||||
Harbin Yew Food Co., Ltd ("HYF") | PRC | RMB100,000(1) | 100% | Sales of wood ear mushroom | |||||
4-Nov-14 | |||||||||
Principles_of_Consolidation_Ta
Principles of Consolidation (Tables) | 3 Months Ended | ||||||||
Mar. 31, 2015 | |||||||||
Principles of Consolidation [Abstract] | |||||||||
Schedule of carrying amount of assets and liabilities related to variable interest entity | March 31, | December 31, | |||||||
2015 | 2014 | ||||||||
Assets | |||||||||
Cash | $ | 107,402 | $ | 446,554 | |||||
Accounts receivable | 2,014,607 | 922,564 | |||||||
Accounts receivable – related party | 1,214,172 | 340,132 | |||||||
Inventories (current and long-term), net | 12,922,693 | 12,106,623 | |||||||
Prepaid expenses and other assets | 27,942 | 5,363 | |||||||
Prepaid expenses - related party | - | 6,600 | |||||||
Property and equipment, net | 786,544 | 814,676 | |||||||
Land use rights and yew forest assets, net | 20,070,176 | 20,305,822 | |||||||
Total assets of VIE | $ | 37,143,536 | $ | 34,948,334 | |||||
Liabilities | |||||||||
Accounts payable | $ | 569,282 | $ | - | |||||
Accrued expenses and other payables | 677,623 | 54,265 | |||||||
Taxes payable | 45,478 | 8,104 | |||||||
Due to VIE holding companies | 1,359,297 | 1,417,851 | |||||||
Due to related parties | 3,593 | 2,958 | |||||||
Total liabilities of VIE | $ | 2,085,992 | $ | 1,483,178 |
Inventories_Tables
Inventories (Tables) | 3 Months Ended | ||||||||||||||||||||||||
Mar. 31, 2015 | |||||||||||||||||||||||||
Inventories [Abstract] | |||||||||||||||||||||||||
Schedule of inventories | 31-Mar-15 | 31-Dec-14 | |||||||||||||||||||||||
Current | Long-term | Total | Current | Long-term | Total | ||||||||||||||||||||
portion | portion | portion | portion | ||||||||||||||||||||||
Raw materials | $ | 86,390 | $ | 2,818,828 | $ | 2,905,218 | $ | 120,478 | $ | 2,798,489 | $ | 2,918,967 | |||||||||||||
Work-in-process | - | - | - | - | 256,227 | 256,227 | |||||||||||||||||||
Finished goods | 782,934 | 753,319 | 1,536,253 | - | 805,438 | 805,438 | |||||||||||||||||||
Yew seedlings and other trees | 1,831,485 | 7,382,961 | 9,214,446 | 1,322,600 | 6,889,573 | 8,212,173 | |||||||||||||||||||
Total | 2,700,809 | 10,955,108 | 13,655,917 | 1,443,078 | 10,749,727 | 12,192,805 | |||||||||||||||||||
Reserve for impairment - handicrafts | - | (85,224 | ) | (85,224 | ) | - | (86,182 | ) | (86,182 | ) | |||||||||||||||
Inventories, net | $ | 2,700,809 | $ | 10,869,884 | $ | 13,570,693 | $ | 1,443,078 | $ | 10,663,545 | $ | 12,106,623 |
Taxes_Tables
Taxes (Tables) | 3 Months Ended | ||||||||
Mar. 31, 2015 | |||||||||
Taxes [Abstract] | |||||||||
Effects of income tax expense exemptions and tax reductions | Three Months Ended | ||||||||
March 31, | |||||||||
2015 | 2014 | ||||||||
Tax exemption effect | $ | 292,331 | $ | 350,294 | |||||
Tax reduction due to loss carry-forwards | 2,355 | 3,021 | |||||||
Loss not subject to income tax | (378 | ) | (832 | ) | |||||
Basic net income per share effect | $ | (0.01 | ) | $ | (0.01 | ) | |||
Diluted net income per share effect | $ | (0.01 | ) | $ | (0.01 | ) | |||
Summary of difference between U.S. statutory federal tax rate and Company's effective tax rate | Three Months Ended | ||||||||
March 31, | |||||||||
2015 | 2014 | ||||||||
U.S. federal income tax rate | 34 | % | 34 | % | |||||
Foreign income not recognized in the U.S. | (34 | )% | (34 | )% | |||||
PRC EIT rate | 25 | % | 25 | % | |||||
PRC tax exemption and reduction | (22 | )% | (25 | )% | |||||
Others | 1 | % | - | ||||||
Total effective income tax rate | 4 | % | - | ||||||
Summary of net deferred tax assets | March 31, | March 31, | |||||||
2015 | 2014 | ||||||||
U.S. tax benefit of net operating loss carry forward | $ | 1,238,220 | $ | 1,119,660 | |||||
Valuation allowance | (1,238,220 | ) | (1,119,660 | ) | |||||
Net deferred tax assets | $ | - | $ | - |
Stockholders_Equity_Tables
Stockholders' Equity (Tables) | 3 Months Ended | ||||||||||||||||||||||
Mar. 31, 2015 | |||||||||||||||||||||||
Stockholders' Equity [Abstract] | |||||||||||||||||||||||
Summary of common stock issuable upon exercise of options outstanding | Stock Options Outstanding | Stock Options Exercisable | |||||||||||||||||||||
Range of | Number | Weighted Average | Weighted | Number | Weighted | ||||||||||||||||||
Exercise Price | Outstanding at | Remaining | Average | Exercisable at | Average | ||||||||||||||||||
March 31, | Contractual Life | Exercise Price | March 31, | Exercise Price | |||||||||||||||||||
2015 | (Years) | 2015 | |||||||||||||||||||||
$ | 0.20-0.23 | 27,205,512 | 2.77 | $ | 0.26 | 22,805,512 | $ | 0.22 |
Earnings_per_Share_Tables
Earnings per Share (Tables) | 3 Months Ended | ||||||||
Mar. 31, 2015 | |||||||||
Earnings Per Share [Abstract] | |||||||||
Reconciliation of basic and diluted net income per share | For the Three Months | ||||||||
Ended March 31, | |||||||||
2015 | 2014 | ||||||||
Net income available to common stockholders for basic and diluted net income per share of common stock | $ | 958,390 | $ | 1,375,241 | |||||
Weighted average common stock outstanding – basic | 52,125,000 | 50,000,000 | |||||||
Effect of dilutive securities: | |||||||||
Non-vested restricted common stock | 58,877 | - | |||||||
Stock options issued to directors/officers/employees | 6,041,714 | 18,118,682 | |||||||
Weighted average common stock outstanding – diluted | 58,225,591 | 68,118,682 | |||||||
Net income per common share – basic | $ | 0.02 | $ | 0.03 | |||||
Net income per common share – diluted | $ | 0.02 | $ | 0.02 |
Concentrations_of_Credit_Risk_1
Concentrations of Credit Risk and Major Customers (Tables) | 3 Months Ended | ||||||||
Mar. 31, 2015 | |||||||||
Customer [Member] | |||||||||
Concentration Risk [Line Items] | |||||||||
Summary of major customers and suppliers | For the Three Months | ||||||||
Ended March 31, | |||||||||
Supplier | 2015 | 2014 | |||||||
A | 25 | % | * | % | |||||
B | 20 | % | * | % | |||||
C | 10 | % | * | % | |||||
Supplier [Member] | |||||||||
Concentration Risk [Line Items] | |||||||||
Summary of major customers and suppliers | For the Three Months | ||||||||
Ended March 31, | |||||||||
Customer | 2015 | 2014 | |||||||
A (Yew Pharmaceutical, a related party) | 41.92 | % | 21.97 | % | |||||
B | * | % | * | % | |||||
C | * | % | * | % | |||||
* Less than 10% |
Related_Party_Transactions_Tab
Related Party Transactions (Tables) | 3 Months Ended | ||
Mar. 31, 2015 | |||
Related Party Transactions [Abstract] | |||
Company's transactions with the related parties | Company | Ownership | |
Heilongjiang Zishan Technology Stock Co., Ltd. (“ZTC”) | 18% owned by Heilongjiang Hongdoushan Ecology Forest Stock Co., Ltd., 39% owned by Zhiguo Wang, Chairman and Chief Executive Officer, 31% owned by Guifang Qi, the wife of Mr. Wang and director of the Company, and 12% owned by third parties. | ||
Heilongjiang Yew Pharmaceutical Co., Ltd. (“Yew Pharmaceutical”) | 95% owned by Heilongjiang Hongdoushan Ecology Forest Stock Co., Ltd., and 5% owned by Madame Qi. | ||
Shanghai Kairun Bio-Pharmaceutical Co., Ltd. (“Kairun”) | 60% owned by Heilongjiang Zishan Technology Co., Ltd., 20% owned by Heilongjiang Hongdoushan Ecology Forest Stock Co., Ltd., and 20% owned by Mr. Wang. | ||
Heilongjiang Hongdoushan Ecology Forest Stock Co., Ltd. (“HEFS”) | 63% owned by Mr. Wang, 34% owned by Madame Qi, and 3% owned by third parties. | ||
Segment_Information_Tables
Segment Information (Tables) | 3 Months Ended | ||||||||||||||||||||||||
Mar. 31, 2015 | |||||||||||||||||||||||||
Segment Information [Abstract] | |||||||||||||||||||||||||
Summary of reportable business segments | |||||||||||||||||||||||||
For the Three Months | |||||||||||||||||||||||||
Ended March 31, | |||||||||||||||||||||||||
2015 | 2014 | ||||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||||
TCM raw materials | $ | 957,006 | $ | 1,043,980 | |||||||||||||||||||||
Yew trees | 698,752 | 964,306 | |||||||||||||||||||||||
Handicrafts | 87,508 | 59,691 | |||||||||||||||||||||||
Wood ear mushroom | 899,189 | - | |||||||||||||||||||||||
$ | 2,642,455 | $ | 2,067,977 | ||||||||||||||||||||||
Cost of revenues: | |||||||||||||||||||||||||
TCM raw materials | $ | 148,325 | $ | 232,340 | |||||||||||||||||||||
Yew trees | 244,848 | 249,331 | |||||||||||||||||||||||
Handicrafts | 13,893 | 46,063 | |||||||||||||||||||||||
Wood ear mushroom | 763,903 | - | |||||||||||||||||||||||
$ | 1,170,969 | $ | 527,734 | ||||||||||||||||||||||
Depreciation and amortization: | |||||||||||||||||||||||||
TCM raw materials | $ | 136,831 | $ | 125,736 | |||||||||||||||||||||
Yew trees | 1,616 | 13,700 | |||||||||||||||||||||||
Handicrafts | 7,065 | 7,819 | |||||||||||||||||||||||
Wood ear mushroom | - | - | |||||||||||||||||||||||
Other | 20,158 | 27,699 | |||||||||||||||||||||||
$ | 165,670 | $ | 174,954 | ||||||||||||||||||||||
Net income (loss): | |||||||||||||||||||||||||
TCM raw materials | $ | 808,682 | $ | 796,227 | |||||||||||||||||||||
Yew trees | 453,904 | 694,336 | |||||||||||||||||||||||
Handicrafts | 73,615 | 14,682 | |||||||||||||||||||||||
Wood ear mushroom | 135,286 | - | |||||||||||||||||||||||
Other | (513,097 | ) | (130,004 | ) | |||||||||||||||||||||
$ | 958,390 | $ | 1,375,241 | ||||||||||||||||||||||
Summary of identifiable long-lived assets, net | |||||||||||||||||||||||||
31-Mar-15 | |||||||||||||||||||||||||
TCM raw materials | Yew | Handicrafts | Wood ear mushroom | Other | Total | ||||||||||||||||||||
trees | |||||||||||||||||||||||||
Identifiable long-lived assets, net | $ | 19,740,199 | $ | 908,146 | $ | 56,684 | $ | - | $ | 195,469 | $ | 20,900,498 | |||||||||||||
31-Dec-14 | |||||||||||||||||||||||||
TCM raw materials | Yew | Handicrafts | Wood ear | Other | Total | ||||||||||||||||||||
trees | mushroom | ||||||||||||||||||||||||
Identifiable long-lived assets, net | $ | 19,973,775 | $ | 915,551 | $ | 63,319 | $ | - | $ | 209,246 | $ | 21,162,071 |
Organization_and_Principal_Act2
Organization and Principal Activities (Details) | 3 Months Ended | ||||
Mar. 31, 2015 | Mar. 31, 2015 | Mar. 31, 2015 | Mar. 31, 2015 | ||
Heilongjiang Jinshangjing Bio-Technology Development Co., Limited ("JSJ") [Member] | Yew Bio-Pharm Holdings Limited ("Yew Bio-Pharm (HK)") [Member] | Harbin Yew Science and Technology Development Co., Ltd. ("HDS") [Member] | Harbin Yew Food Co., Ltd ("HYF") [Member] | ||
USD ($) | HKD | CNY | CNY | ||
Schedule of Company's subsidiaries and variable interest entities | |||||
Domicile and Date of Incorporation | PRC October 29, 2009 | Hong Kong November 29, 2010 | PRC August 22, 1996 | PRC November 4, 2014 | |
Registered Capital | $100,000 | 10,000 | 45,000,000 | 100,000 | [1] |
Effective ownership, percentage | 100.00% | 100.00% | 100.00% | ||
Effective Ownership | Contractual arrangements | ||||
Principal Activities | Holding company | Holding company of JSJ | Sales of yew tree components for use in pharmaceutical industry; sales of yew tree seedlings and potted yew trees; manufacture of yew tree wood handicrafts; and sales of wood ear mushroom | Sales of wood ear mushroom | |
[1] | Harbin Yew Food Co. Ltd did not pay the registered capital as of March 31, 2015. |
Principles_of_Consolidation_De
Principles of Consolidation (Details) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
Schedule of carrying amount of assets and liabilities related to variable interest entity | ||
Total assets of VIE | $37,143,536 | $34,948,334 |
Total liabilities of VIE | 2,085,992 | 1,483,178 |
Cash [Member] | ||
Schedule of carrying amount of assets and liabilities related to variable interest entity | ||
Total assets of VIE | 107,402 | 446,554 |
Accounts receivable [Member] | ||
Schedule of carrying amount of assets and liabilities related to variable interest entity | ||
Total assets of VIE | 2,014,607 | 922,564 |
Accounts receivable - related party [Member] | ||
Schedule of carrying amount of assets and liabilities related to variable interest entity | ||
Total assets of VIE | 1,214,172 | 340,132 |
Inventories (current and long-term), net [Member] | ||
Schedule of carrying amount of assets and liabilities related to variable interest entity | ||
Total assets of VIE | 12,922,693 | 12,106,623 |
Prepaid expenses and other assets [Member] | ||
Schedule of carrying amount of assets and liabilities related to variable interest entity | ||
Total assets of VIE | 27,942 | 5,363 |
Prepaid expenses - related party [Member] | ||
Schedule of carrying amount of assets and liabilities related to variable interest entity | ||
Total assets of VIE | 6,600 | |
Property and equipment, net [Member] | ||
Schedule of carrying amount of assets and liabilities related to variable interest entity | ||
Total assets of VIE | 786,544 | 814,676 |
Land use rights and yew forest assets, net [Member] | ||
Schedule of carrying amount of assets and liabilities related to variable interest entity | ||
Total assets of VIE | 20,070,176 | 20,305,822 |
Accounts Payable [Member] | ||
Schedule of carrying amount of assets and liabilities related to variable interest entity | ||
Total liabilities of VIE | 569,282 | |
Accrued expenses and other payables [Member] | ||
Schedule of carrying amount of assets and liabilities related to variable interest entity | ||
Total liabilities of VIE | 677,623 | 54,265 |
Taxes payable [Member] | ||
Schedule of carrying amount of assets and liabilities related to variable interest entity | ||
Total liabilities of VIE | 45,478 | 8,104 |
Due to VIE holding companies [Member] | ||
Schedule of carrying amount of assets and liabilities related to variable interest entity | ||
Total liabilities of VIE | 1,359,297 | 1,417,851 |
Due to related parties [Member] | ||
Schedule of carrying amount of assets and liabilities related to variable interest entity | ||
Total liabilities of VIE | $3,593 | $2,958 |
Principles_of_Consolidation_De1
Principles of Consolidation (Details Textual) (CNY) | 3 Months Ended |
Mar. 31, 2015 | |
Principles of Consolidation (Textual) | |
Monthly consulting service fee as percentage of net income of HDS paid to JSJ | 100.00% |
HDS obligation within 30 days after the end of each month | Within 30 days after the end of each month, HDS shall (a) deliver to JSJ the management accounts and operating statistics of HDS for such month, including the net income of HDS during such month (the "Monthly Net Income"), and (b) pay 80% of such Monthly Net Income to JSJ (each such payment, a "Monthly Payment"). |
HDS obligation within 90 days after the end of each month | Within ninety (90) days after the end of each fiscal year, HDS shall (a) deliver to JSJ financial statements of HDS for such fiscal year, which shall be audited and certified by an independent certified public accountant approved by JSJ, and (b) pay an amount to JSJ equal to the shortfall, if any, of the aggregate net income of HDS for such fiscal year, as shown in such audited financial statements, as compared to the aggregate amount of the Monthly Payments paid by HDS to JSJ in such fiscal year. HDS also granted an irrevocable and exclusive option to JSJ to purchase any and all of the assets of HDS, to the extent permitted under PRC law, at the lowest price permitted by PRC law. |
Additional monthly payment to JSJ as percentage of net income of HDS | 80.00% |
Business Cooperation Agreement term | 10 years |
Business Cooperation Agreement expiration date | 5-Nov-20 |
Notice period for JSJ to termination of contract | 30 days |
HDS Shareholder's equity interests | 10 |
Execution of any major contract is limited under Option Agreement | Over RMB 500,000 |
Exclusive Option Agreement term | 10 years |
Exclusive Option Agreement commencing date | 5-Nov-20 |
Description of notice period for remedies for any breach in terms agreement | Within 20 days after the giving of notice of breach. |
Inventories_Details
Inventories (Details) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
Schedule of inventories | ||
Current portion | $2,700,809 | $1,443,078 |
Long-term portion | 10,869,884 | 10,663,545 |
Total | 13,570,693 | 12,106,623 |
Raw materials [Member] | ||
Schedule of inventories | ||
Current portion | 86,390 | 120,478 |
Long-term portion | 2,818,828 | 2,798,489 |
Total | 2,905,218 | 2,918,967 |
Work-in-process [Member] | ||
Schedule of inventories | ||
Current portion | ||
Long-term portion | 256,227 | |
Total | 256,227 | |
Finished goods [Member] | ||
Schedule of inventories | ||
Current portion | 782,934 | |
Long-term portion | 753,319 | 805,438 |
Total | 1,536,253 | 805,438 |
Yew seedlings and other trees [Member] | ||
Schedule of inventories | ||
Current portion | 1,831,485 | 1,322,600 |
Long-term portion | 7,382,961 | 6,889,573 |
Total | 9,214,446 | 8,212,173 |
Total [Member] | ||
Schedule of inventories | ||
Current portion | 2,700,809 | 1,443,078 |
Long-term portion | 10,955,108 | 10,749,727 |
Total | 13,655,917 | 12,192,805 |
Reserve for impairment - handicrafts [Member] | ||
Schedule of inventories | ||
Current portion | ||
Long-term portion | -85,224 | -86,182 |
Total | ($85,224) | ($86,182) |
Taxes_Details
Taxes (Details) (USD $) | 3 Months Ended | |
Mar. 31, 2015 | Mar. 31, 2014 | |
Effects of income tax expense exemptions and tax reductions | ||
Tax exemption effect | $292,331 | $350,294 |
Tax reduction due to loss carry-forwards | 2,355 | 3,021 |
Loss not subject to income tax | ($378) | ($832) |
Basic net income per share effect | ($0.01) | ($0.01) |
Diluted net income per share effect | ($0.01) | ($0.01) |
Taxes_Details_1
Taxes (Details 1) | 3 Months Ended | |
Mar. 31, 2015 | Mar. 31, 2014 | |
Summary of difference between U.S. statutory federal tax rate and Company's effective tax rate | ||
U.S. federal income tax rate | 34.00% | 34.00% |
Foreign income not recognized in the U.S. | -34.00% | -34.00% |
PRC EIT rate | 25.00% | 25.00% |
PRC tax exemption and reduction | -22.00% | -25.00% |
Others | 1.00% | |
Total effective income tax rate | 4.00% |
Taxes_Details_2
Taxes (Details 2) (USD $) | Mar. 31, 2015 | Mar. 31, 2014 |
Summary of deferred tax assets and liabilities | ||
U.S. tax benefit of net operating loss carry forward | $1,238,220 | $1,119,660 |
Valuation allowance | -1,238,220 | -1,119,660 |
Net deferred tax assets |
Taxes_Details_Textual
Taxes (Details Textual) (USD $) | 3 Months Ended | |
Mar. 31, 2015 | Mar. 31, 2014 | |
Taxes (Textual) | ||
Income before income tax expense | $999,529 | $1,375,241 |
Net operating loss carry forwards | 3,641,823 | 3,293,117 |
Operating loss carry forwards expires | Through 2035 | |
Valuation allowance, percentage | 100.00% | |
Valuation allowance | 1,238,220 | 1,119,660 |
Net change in valuation allowance | 121,864 | 11,795 |
Cumulative undistributed earnings of foreign subsidiary and VIE | 25,900,000 | 24,700,000 |
Value added tax for agricultural products | 13.00% | |
Value added tax for handicrafts | 17.00% | |
Description of Value added tax exemption date | Up to December 31, 2016 | |
U.S. federal income tax rate | 34.00% | 34.00% |
PRC EIT rate | 25.00% | 25.00% |
PROVISION FOR INCOME TAXES | $41,139 |
Stockholders_Equity_Details_1
Stockholders' Equity (Details 1) (USD $) | 3 Months Ended |
Mar. 31, 2015 | |
Summary of number of shares of the company's common stock subjedt to each Founder's Option | |
Stock Options Outstanding | 27,205,512 |
Weighted Average Remaining Contractual Life (Years) | 2 years 9 months 7 days |
Stock Options Outstanding, Weighted Average Exercise Price | $0.26 |
Stock Options Exercisable | 22,805,512 |
Stock Options Exercisable, Weighted Average Exercise Price | $0.22 |
Minimum [Member] | |
Summary of number of shares of the company's common stock subjedt to each Founder's Option | |
Range of exercise price | $0.20 |
Maximum [Member] | |
Summary of number of shares of the company's common stock subjedt to each Founder's Option | |
Range of exercise price | $0.23 |
Stockholders_Equity_Details_Te
Stockholders' Equity (Details Textual) (USD $) | 3 Months Ended | 0 Months Ended | 1 Months Ended | ||
Mar. 31, 2015 | Mar. 31, 2014 | Jul. 22, 2014 | Jul. 18, 2014 | Nov. 18, 2014 | |
Stockholders Equity (Textual) | |||||
Aggregate intrinsic value | $1,878,386 | $1,596,386 | |||
Closing stock price | $0.29 | ||||
Share-based Compensation | 294,239 | ||||
2012 Equity Incentive Plan [Member] | |||||
Stockholders Equity (Textual) | |||||
Exercise price of per share | 0.23 | ||||
Service Provider Agreement [Member] | |||||
Stockholders Equity (Textual) | |||||
Restricted common stock for the service period | 1,250,000 | ||||
Total restricted shares award, value | $8,383 | ||||
Time Period One [Member] | Service Provider Agreement [Member] | |||||
Stockholders Equity (Textual) | |||||
Restricted common stock for the service period | 875,000 | ||||
Time Period Two [Member] | Service Provider Agreement [Member] | |||||
Stockholders Equity (Textual) | |||||
Restricted common stock for the service period | 375,000 | ||||
Option [Member] | |||||
Stockholders Equity (Textual) | |||||
Options was issued shares of common stock of the Company | 200,000 | ||||
Exercise price of per share | $0.20 | ||||
Option, Expiration period | 4 years | ||||
Option, Expiration date | 1-Aug-18 | ||||
Options vesting period | 3 years | ||||
Option [Member] | Time Period One [Member] | |||||
Stockholders Equity (Textual) | |||||
Option vested, Percentage | 30.00% | ||||
Option vested, date | 12 months | ||||
Option [Member] | Time Period Two [Member] | |||||
Stockholders Equity (Textual) | |||||
Option vested, Percentage | 35.00% | ||||
Option vested, date | 24 months | ||||
Option [Member] | Time Period Three [Member] | |||||
Stockholders Equity (Textual) | |||||
Option vested, Percentage | 35.00% | ||||
Option vested, date | 36 months | ||||
Option One [Member] | 2012 Equity Incentive Plan [Member] | |||||
Stockholders Equity (Textual) | |||||
Option, Expiration period | 4 years | ||||
Option, Expiration date | 18-Nov-18 | ||||
Stock options vesting period description | The options vest over a three-year time period from November 18, 2014, and 30%, 35%, and 35% of the total shares granted shall vest and become exercisable 12, 24, and 36 months after the initial vesting commencement date. | ||||
Employee Stock Option Two [Member] | 2012 Equity Incentive Plan [Member] | |||||
Stockholders Equity (Textual) | |||||
Option, Expiration period | 2 years | ||||
Option, Expiration date | 18-Nov-18 | ||||
Stock options vesting period description | (2) The option has a term of two years starting from November 18, 2014, the vesting commencement date, and expires on November 18, 2016. The options vest over a one-year time period from November 18, 2014, and 100% of the total shares granted shall vest and become exercisable 12 months after the initial vesting commencement date. | ||||
Employee Stock Option Three [Member] | 2012 Equity Incentive Plan [Member] | |||||
Stockholders Equity (Textual) | |||||
Option, Expiration period | 3 years | ||||
Option, Expiration date | 18-Nov-17 | ||||
Stock options vesting period description | (3) The option has a term of three years starting from November 18, 2014, the vesting commencement date, and expires on November 18, 2017. The options vest over a two-year time period, and 50% and the remaining 50% of the total shares shall vest and become exercisable 12 and 24 months respectively after the initial vesting commencement date. |
Earnings_Per_Share_Details
Earnings Per Share (Details) (USD $) | 3 Months Ended | |
Mar. 31, 2015 | Mar. 31, 2014 | |
Reconciliation of basic and diluted net income per share | ||
Net income available to common stockholders for basic and diluted net income per share of common stock | $958,390 | $1,375,241 |
Weighted average common stock outstanding - basic | 52,125,000 | 50,000,000 |
Effect of dilutive securities: | ||
Non-vested restricted common stock | 58,877 | |
Stock options issued to directors/officers/employees | 6,041,714 | 18,118,682 |
Weighted average common stock outstanding - diluted | 58,225,591 | 68,118,682 |
Net income per common share - basic | $0.02 | $0.03 |
Net income per common share - diluted | $0.02 | $0.02 |
Concentrations_of_Credit_Risk_2
Concentrations of Credit Risk and Major Customers (Details) | 3 Months Ended | |||
Mar. 31, 2015 | Mar. 31, 2014 | |||
A (Yew Pharmaceutical, a related party) [Member] | ||||
Summary of major customer | ||||
Percentage of revenue from major customers | 41.92% | 21.97% | ||
B [Member] | ||||
Summary of major customer | ||||
Percentage of revenue from major customers | [1] | [1] | ||
C [Member] | ||||
Summary of major customer | ||||
Percentage of revenue from major customers | [1] | [1] | ||
[1] | Less than 10% |
Concentrations_of_Credit_Risk_3
Concentrations of Credit Risk and Major Customers (Details 1) | 3 Months Ended | ||
Mar. 31, 2015 | Mar. 31, 2014 | ||
A [Member] | |||
Summary of major suppliers | |||
Percentage of revenue from major suppliers | 25.00% | [1] | |
B [Member] | |||
Summary of major suppliers | |||
Percentage of revenue from major suppliers | 20.00% | [1] | |
C [Member] | |||
Summary of major suppliers | |||
Percentage of revenue from major suppliers | 10.00% | [1] | |
[1] | Less than 10% |
Concentrations_of_Credit_Risk_4
Concentrations of Credit Risk and Major Customers (Details Textual) (USD $) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2015 | Mar. 31, 2014 | Dec. 31, 2014 | |
Supplier | |||
Revenue [Member] | |||
Concentrations of Credit Risk and Major Customers (Textual) | |||
Concentration risk, Percentage | 10.00% | 10.00% | |
Purchase [Member] | |||
Concentrations of Credit Risk and Major Customers (Textual) | |||
Concentration risk, Percentage | 10.00% | 10.00% | |
Percentage Of Accounts Receivable Accounted By Largest Suppliers | 55.00% | ||
Accounts payable to supplier | $0 | ||
Number Of Largest Suppliers Accounted In Accounts Receivable | 3 | ||
Accounts Receivable [Member] | |||
Concentrations of Credit Risk and Major Customers (Textual) | |||
Concentration risk, Percentage | 49.00% | 36.00% | |
Number Of Largest Customers Accounted In Accounts Receivable | 3 | ||
Accounts Receivable [Member] | Related Party [Member] | |||
Concentrations of Credit Risk and Major Customers (Textual) | |||
Concentration risk, Percentage | 38.00% | 27.00% |
Related_Party_Transactions_Det
Related Party Transactions (Details) | 3 Months Ended |
Mar. 31, 2015 | |
Heilongjiang Zishan Technology Stock Co., Ltd. ("ZTC") [Member] | |
Related Party Transaction [Line Items] | |
Ownership, description | 18% owned by Heilongjiang Hongdoushan Ecology Forest Stock Co., Ltd., 39% owned by Zhiguo Wang, Chairman and Chief Executive Officer, 31% owned by Guifang Qi, the wife of Mr. Wang and Director of the Company, and 12% owned by third parties. |
Heilongjiang Yew Pharmaceuticals, Co., Ltd. ("Yew Pharmaceutical") [Member] | |
Related Party Transaction [Line Items] | |
Ownership, description | 95% owned by Heilongjiang Hongdoushan Ecology Forest Stock Co., Ltd., and 5% owned by Madame Qi. |
Shanghai Kairun Bio-Pharmaceutical Co., Ltd. ("Kairun") [Member] | |
Related Party Transaction [Line Items] | |
Ownership, description | 60% owned by Heilongjiang Zishan Technology Co., Ltd., 20% owned by Heilongjiang Hongdoushan Ecology Forest Stock Co., Ltd., and 20% owned by Mr. Wang. |
Heilongjiang Hongdoushan Ecology Forest Stock Co., Ltd. ("HEFS") [Member] | |
Related Party Transaction [Line Items] | |
Ownership, description | 63% owned by Mr. Wang, 34% owned by Madame Qi, and 3% owned by third parties. |
Related_Party_Transactions_Det1
Related Party Transactions (Details Textual) | Mar. 31, 2015 | Dec. 31, 2014 | Mar. 25, 2005 | Mar. 25, 2005 | Mar. 31, 2015 | Mar. 31, 2014 | Dec. 31, 2014 | Jan. 01, 2010 | Jan. 01, 2010 | Mar. 31, 2015 | Mar. 31, 2014 | Jul. 01, 2012 | Jul. 01, 2012 | Mar. 31, 2015 | Mar. 31, 2014 | Feb. 01, 2015 | Mar. 31, 2015 | Mar. 31, 2015 | Mar. 31, 2014 | Jan. 09, 2010 | Jan. 09, 2010 | Jan. 01, 2010 | Jan. 01, 2010 |
USD ($) | USD ($) | Agreement of Seedling Land with ZTC [Member] | Agreement of Seedling Land with ZTC [Member] | Agreement of Seedling Land with ZTC [Member] | Agreement of Seedling Land with ZTC [Member] | Agreement of Seedling Land with ZTC [Member] | Office Lease [Member] | Office Lease [Member] | Office Lease [Member] | Office Lease [Member] | JSJ Lease [Member] | JSJ Lease [Member] | JSJ Lease [Member] | JSJ Lease [Member] | Warehouse Lease [Member] | Warehouse Lease [Member] | Yew Pharmaceutical [Member] | Yew Pharmaceutical [Member] | Yew Pharmaceutical [Member] | Yew Pharmaceutical [Member] | Kairun [Member] | Kairun [Member] | |
USD ($) | CNY | USD ($) | USD ($) | USD ($) | USD ($) | CNY | USD ($) | USD ($) | USD ($) | CNY | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Cooperation and Development Agreement [Member] | Cooperation and Development Agreement [Member] | Technology Agreement [Member] | Technology Agreement [Member] | |||
acre | sqm | sqft | USD ($) | CNY | USD ($) | CNY | |||||||||||||||||
Related Party Transactions (Textual) | |||||||||||||||||||||||
Agreement expiration date | 24-Mar-35 | 24-Mar-35 | 31-Dec-25 | 31-Dec-25 | 30-Jun-15 | 30-Jun-15 | 31-Jan-16 | 9-Jan-20 | 9-Jan-20 | ||||||||||||||
Cultivation price per metric ton | $158,000 | 1,000,000 | |||||||||||||||||||||
Sales | 1,107,801 | 454,259 | |||||||||||||||||||||
Accounts receivable, related parties, current | 1,214,172 | 340,132 | |||||||||||||||||||||
Agreement expiration period | 30 years | 30 years | 15 years | 15 years | 3 years | 3 years | 10 years | 10 years | 2 years | 2 years | |||||||||||||
Annual payments under operating lease | 26,000 | 162,450 | 2,000 | 15,000 | 1,600 | 10,000 | |||||||||||||||||
Subsequent period for which company required to make full payment for land use rights in advance | 5 years | 5 years | |||||||||||||||||||||
Prepaid rent - related party | 5,787 | 6,600 | |||||||||||||||||||||
Operating Leases, rent expense | 6,619 | 6,636 | 611 | 613 | 407 | 409 | 3,400 | 6,523 | |||||||||||||||
Leased Area | 361 | 361 | 30 | 30 | 3,706 | ||||||||||||||||||
Due to related parties | 46,903 | 45,040 | |||||||||||||||||||||
Payment made under agreement | $32,000 | 200,000 |
Statutory_Reserves_Details
Statutory Reserves (Details) (USD $) | 3 Months Ended | ||
Mar. 31, 2015 | Mar. 31, 2014 | Dec. 31, 2014 | |
Statutory Reserves (Textual) | |||
Appropriation of statutory surplus reserve, Description | Appropriation to the statutory surplus reserve is required to be at least 10% of the after tax net income determined in accordance with PRC GAAP until the reserve is equal to 50% of the entities' registered capital. Appropriations to the discretionary surplus reserve are made at the discretion of the Board of Directors. | ||
Statutory surplus reserve fund, Description | The statutory surplus reserve fund is non-distributable other than during liquidation and can be used to fund previous years' losses, if any, and may be utilized for business expansion or converted into share capital by issuing new shares to existing shareholders in proportion to their shareholding or by increasing the par value of the shares currently held by them, provided that the remaining reserve balance after such issue is not less than 25% of the registered capital. | ||
Maximum percentage balance required of registered capital in reserve for business expansion | 50.00% | ||
Appropriated to statutory surplus reserve | $134,330 | $141,326 | |
Accumulated balance of the statutory reserve | $3,234,048 | $3,100,766 |
Segment_Information_Details
Segment Information (Details) (USD $) | 3 Months Ended | ||
Mar. 31, 2015 | Mar. 31, 2014 | Dec. 31, 2014 | |
Summary of reportable business segments | |||
Total Revenues | $2,642,455 | $2,067,977 | |
Total Cost of Revenues | 1,170,969 | 527,734 | |
Depreciation and amortization | 165,670 | 174,954 | |
Net income (loss) | 958,390 | 1,375,241 | |
Segment reporting information, Additional information | |||
Identifiable long-lived assets, net | 20,900,498 | 21,162,071 | |
TCM raw materials [Member] | |||
Summary of reportable business segments | |||
Total Revenues | 957,006 | 1,043,980 | |
Total Cost of Revenues | 148,325 | 232,340 | |
Depreciation and amortization | 136,831 | 125,736 | |
Net income (loss) | 808,682 | 796,227 | |
Segment reporting information, Additional information | |||
Identifiable long-lived assets, net | 19,740,199 | 19,973,775 | |
Yew trees [Member] | |||
Summary of reportable business segments | |||
Total Revenues | 698,752 | 964,306 | |
Total Cost of Revenues | 244,848 | 249,331 | |
Depreciation and amortization | 1,616 | 13,700 | |
Net income (loss) | 453,904 | 694,336 | |
Segment reporting information, Additional information | |||
Identifiable long-lived assets, net | 908,146 | 915,551 | |
Handicrafts [Member] | |||
Summary of reportable business segments | |||
Total Revenues | 87,508 | 59,691 | |
Total Cost of Revenues | 13,893 | 46,063 | |
Depreciation and amortization | 7,065 | 7,819 | |
Net income (loss) | 73,615 | 14,682 | |
Segment reporting information, Additional information | |||
Identifiable long-lived assets, net | 56,684 | 63,319 | |
Wood Ear Mushroom [Member] | |||
Summary of reportable business segments | |||
Total Revenues | 899,189 | ||
Total Cost of Revenues | 763,903 | ||
Depreciation and amortization | |||
Net income (loss) | 135,286 | ||
Segment reporting information, Additional information | |||
Identifiable long-lived assets, net | |||
Other [Member] | |||
Summary of reportable business segments | |||
Depreciation and amortization | 20,158 | 27,699 | |
Net income (loss) | -513,097 | -130,004 | |
Segment reporting information, Additional information | |||
Identifiable long-lived assets, net | $195,469 | $209,246 |
Segment_Information_Details_Te
Segment Information (Details Textual) | 3 Months Ended |
Mar. 31, 2015 | |
Supplier | |
Segment Information (Textual) | |
Number of business segments | 4 |
Subsequent_Events_Details
Subsequent Events (Details) (Subsequent Event [Member]) | 1 Months Ended | |
Apr. 23, 2015 | Apr. 23, 2015 | |
USD ($) | CNY | |
Subsequent Event [Line Items] | ||
Loan payable | $1,630,000 | 10,000,000 |
Percentage of loan interest rate | 6.96% | 6.96% |
Loan contract, description | The loan carries an annual interest rate of 6.955% and is secured by the assets of ZTC which is owned by Mr. Zhiguo Wang, the CEO and principal stock holder of the Company. | The loan carries an annual interest rate of 6.955% and is secured by the assets of ZTC which is owned by Mr. Zhiguo Wang, the CEO and principal stock holder of the Company. |
Loan payable date | 22-Apr-16 | 22-Apr-16 |